Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease

The purpose of this study is to determine the prevalence of pulmonary embolism in our population of Chronic Obstructive Pulmonary Disease (COPD) patients admitted to hospital with dyspnea. The patients will undergo investigation for pulmonary embolism, according to current guidelines.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pulmonary Embolism Cardiovascular Diseases Chronic Disease Chronic Obstructive Pulmonary Disease Disease Attributes Embolism Embolism and Thrombosis Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sykehuset Innlandet

Lillehammer, Oppland, 2381, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

known or suspected COPD
COPD-exacerbation

Exclusion criteria

other causes of dyspnea
unable to perform CT pulmonary angio (contrast allergy, pregnancy)
already included in the study (each patient included only once)
use of anticoagulants

Treatment and study plan

Primary outcomes

Prevalence of pulmonary embolism in exacerbations of COPD

Time frame: one year

Sponsors and collaborators

Lead sponsor

Sykehuset Innlandet HF

Other

Registry information

Official study title

Prevalence of Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease

Important dates

Study start: 2011
Primary completion: 2012
Study completion: 2013
First posted: Mar 18, 2011
Registry last updated: Jul 8, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed